RxDoctor Payments Data

Scott Philburn, PA

Physician Assistant · Cadillac, MINPI 1386984920

Payments from drug & device makers

$5,103in general payments, 2019–2025

Across 292 payments — averaging $17.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$864
  • Novo Nordisk$619
  • Boehringer Ingelheim$349
  • Lilly USA, LLC$323
  • Otsuka America Pharmaceutical, Inc.$289
  • Pfizer$246
  • plus $2K from 39 others

What the payments were for

  • Food & beverage$5,103100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,103 in reported general payments places this provider in the 90th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$28,269
Medicare patients
140
Services billed
802

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin68$61,341
EliquisApixaban33$38,981
Trelegy ElliptaFluticasone/Umeclidin/Vilanter46$33,110
TrulicityDulaglutide14$26,304
OzempicSemaglutide13$16,120
FarxigaDapagliflozin Propanediol15$11,342
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$6,980
Atorvastatin Calcium227$3,495
ShingrixVaricella-Zoster Ge/As01b/Pf12$2,698
Albuterol Sulfate HfaAlbuterol Sulfate55$2,084
Losartan Potassium126$1,847
Amlodipine Besylate156$1,622
Adacel TdapDiph,pertuss(Acell),tet Vac/Pf20$1,464
Omeprazole134$1,456
Lisinopril134$1,450

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$349$61,34168 claims
PfizerEliquis$246$38,98133 claims
GSKTrelegy Ellipta, Shingrix$152$35,80858 claims
Lilly USA, LLCTrulicity$323$26,30414 claims
AstraZenecaFarxiga, Breztri Aerosphere$246$18,32126 claims
Novo NordiskOzempic$619$16,12013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Cadillac

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →